Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

In vivo screening of hepatocellular carcinoma using AC susceptibility of anti-alpha fetoprotein-activated magnetic nanoparticles.

Chieh JJ, Huang KW, Lee YD, Horng HE, Yang HC, Hong CY.

PLoS One. 2012;7(10):e46756. doi: 10.1371/journal.pone.0046756.

2.

Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe3O4 magnetic nanoparticles.

Huang KW, Chieh JJ, Horng HE, Hong CY, Yang HC.

Int J Nanomedicine. 2012;7:2987-96. doi: 10.2147/IJN.S30061.

3.

Dual-imaging model of SQUID biosusceptometry for locating tumors targeted using magnetic nanoparticles.

Chieh JJ, Huang KW, Lee YY, Wei WC.

J Nanobiotechnology. 2015 Feb 12;13:11. doi: 10.1186/s12951-015-0069-5.

4.

Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles.

Huang KW, Yang SY, Hong YW, Chieh JJ, Yang CC, Horng HE, Wu CC, Hong CY, Yang HC.

Int J Nanomedicine. 2012;7:1991-6. doi: 10.2147/IJN.S28245.

6.

In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector.

Kim KI, Park JH, Lee YJ, Lee TS, Park JJ, Song I, Nahm SS, Cheon GJ, Lim SM, Chung JK, Kang JH.

J Gene Med. 2012 Aug;14(8):513-20. doi: 10.1002/jgm.2648.

PMID:
22761128
7.

A noninvasive method to determine the fate of Fe(3)O(4) nanoparticles following intravenous injection using scanning SQUID biosusceptometry.

Tseng WK, Chieh JJ, Yang YF, Chiang CK, Chen YL, Yang SY, Horng HE, Yang HC, Wu CC.

PLoS One. 2012;7(11):e48510. doi: 10.1371/journal.pone.0048510.

8.

Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.

Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L, Wu XH.

Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):538-44.

9.

Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy.

Entezami M, Becker R, Ebert A, Pritze W, Weitzel H.

Gynecol Oncol. 1996 Sep;62(3):405-7.

PMID:
8812541
10.

A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.

Hsu SX, Siegel AB, Berk PD.

Semin Liver Dis. 2010 Feb;30(1):99-106. doi: 10.1055/s-0030-1247136.

PMID:
20175037
11.

Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.

Debruyne EN, Delanghe JR.

Clin Chim Acta. 2008 Sep;395(1-2):19-26. doi: 10.1016/j.cca.2008.05.010. Review.

PMID:
18538135
12.

Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.

Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K.

J Gastroenterol Hepatol. 2011 Jul;26(7):1195-200. doi: 10.1111/j.1440-1746.2011.06720.x.

PMID:
21410750
13.

[Alpha-fetoprotein: diagnostic value in hepatic disorders].

Kreczko S, Lipska A, Wysocka J.

Pol Merkur Lekarski. 2000 Jun;8(48):420-3. Review. Polish.

PMID:
10967924
14.

The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.

Peng YC, Chan CS, Chen GH.

Hepatogastroenterology. 1999 Nov-Dec;46(30):3208-11.

PMID:
10626187
15.

A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.

Shimauchi Y, Tanaka M, Kuromatsu R, Ogata R, Tateishi Y, Itano S, Ono N, Yutani S, Nagamatsu H, Matsugaki S, Yamasaki S, Tanikawa K, Sata M.

Oncol Rep. 2000 Mar-Apr;7(2):249-56.

PMID:
10671666
16.

Clinical biomarkers in hepatocellular carcinoma (HCC).

Donati M, Brancato G, Donati A.

Front Biosci (Schol Ed). 2010 Jan 1;2:571-7. Review.

PMID:
20036969
17.
18.

Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.

Khien VV, Mao HV, Chinh TT, Ha PT, Bang MH, Lac BV, Hop TV, Tuan NA, Don LV, Taketa K, Satomura S.

Int J Biol Markers. 2001 Apr-Jun;16(2):105-11.

PMID:
11471892
19.

Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.

Sato K, Tanaka M, Kusaba T, Fukuda H, Tanikawa K.

Oncol Rep. 1998 Mar-Apr;5(2):355-8.

PMID:
9468556
20.
Items per page

Supplemental Content

Support Center